These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33717055)

  • 21. Pyridoxine increases nitric oxide biosynthesis in human platelets.
    Wu Y; Liu Y; Han Y; Cui B; Mi Q; Huang Y; Wang L; Jiang Q; Chen Q; Liu N; Ferro A; Ji Y
    Int J Vitam Nutr Res; 2009 Mar; 79(2):95-103. PubMed ID: 20108211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sulforaphane prevents human platelet aggregation through inhibiting the phosphatidylinositol 3-kinase/Akt pathway.
    Chuang WY; Kung PH; Kuo CY; Wu CC
    Thromb Haemost; 2013 Jun; 109(6):1120-30. PubMed ID: 23426129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADP-Mediated Upregulation of Expression of CD62P on Human Platelets Is Critically Dependent on Co-Activation of P2Y1 and P2Y12 Receptors.
    Anderson R; Theron AJ; Steel HC; Nel JG; Tintinger GR
    Pharmaceuticals (Basel); 2020 Nov; 13(12):. PubMed ID: 33255391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets.
    Soslau G; McKenzie RJ; Brodsky I; Devlin TM
    Biochim Biophys Acta; 1995 Jul; 1268(1):73-80. PubMed ID: 7626665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADP secretion and subsequent P2Y12 receptor signalling play a crucial role in thrombin-induced ERK2 activation in human platelets.
    Fälker K; Lange D; Presek P
    Thromb Haemost; 2004 Jul; 92(1):114-23. PubMed ID: 15213852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clofazimine, but Not Isoniazid or Rifampicin, Augments Platelet Activation
    Anderson R; Theron AJ; Nel JG; Durandt C; Cholo MC; Feldman C; Tintinger GR
    Front Pharmacol; 2018; 9():1335. PubMed ID: 30515097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The P2Y1 receptor mediates ADP-induced p38 kinase-activating factor generation in human platelets.
    Dangelmaier C; Jin J; Daniel JL; Smith JB; Kunapuli SP
    Eur J Biochem; 2000 Apr; 267(8):2283-9. PubMed ID: 10759852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced platelet aggregation and activation under conditions of hypothermia.
    Xavier RG; White AE; Fox SC; Wilcox RG; Heptinstall S
    Thromb Haemost; 2007 Dec; 98(6):1266-75. PubMed ID: 18064324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
    Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
    Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
    Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K
    Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway.
    Dangelmaier C; Jin J; Smith JB; Kunapuli SP
    Thromb Haemost; 2001 Feb; 85(2):341-8. PubMed ID: 11246558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
    Puri RN; Colman RW
    J Cell Biochem; 1996 Apr; 61(1):97-108. PubMed ID: 8726359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of flow cytometry in the measurement of platelet activation and aggregation in human immunodeficiency virus infection.
    Nkambule BB; Davison G; Ipp H
    Platelets; 2015; 26(3):250-7. PubMed ID: 24831969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
    Lockhart LK; McNicol A
    J Pharmacol Exp Ther; 1999 May; 289(2):721-8. PubMed ID: 10215645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors.
    Paul BZ; Jin J; Kunapuli SP
    J Biol Chem; 1999 Oct; 274(41):29108-14. PubMed ID: 10506165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DL-3-n-butylphthalide inhibits platelet activation via inhibition of cPLA2-mediated TXA2 synthesis and phosphodiesterase.
    Ye J; Zhai L; Zhang S; Zhang Y; Chen L; Hu L; Zhang S; Ding Z
    Platelets; 2015; 26(8):736-44. PubMed ID: 25734213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of platelet activation and thrombus formation using a pan-PI3K inhibitor S14161.
    Yi W; Li Q; Shen J; Ren L; Liu X; Wang Q; He S; Wu Q; Hu H; Mao X; Zhu L
    PLoS One; 2014; 9(8):e102394. PubMed ID: 25115838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa).
    Andrioli G; Minuz P; Solero P; Pincelli S; Ortolani R; Lussignoli S; Bellavite P
    Br J Haematol; 2000 Sep; 110(4):911-8. PubMed ID: 11054082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholesterol enrichment of rabbit platelets enhances the Ca(2+) entry pathway induced by platelet-derived secondary feedback agonists.
    Shiraishi M; Tamura K; Egoshi M; Miyamoto A
    Life Sci; 2013 May; 92(14-16):838-44. PubMed ID: 23499558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet CD40 ligand (CD40L)--subcellular localization, regulation of expression, and inhibition by clopidogrel.
    Hermann A; Rauch BH; Braun M; Schrör K; Weber AA
    Platelets; 2001 Mar; 12(2):74-82. PubMed ID: 11297035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.